Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza H3N2 Challenge Study for Breath Biomarkers
NCT06476275Phase 1Completed
- Sponsor
- Duke University
- Start
- Sep 2024
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Duke University. Primary endpoints: Number of participants with detectable viral shedding in nasopharyngeal (NP) swab(s) by qualitative RT-PCR over any 2 days and with symptomatic infection, Number of participants with On-breath volatile markers that correlate with clinical symptoms and 1 more. Started Sep 2024; status: completed.
Beyond the preview
Go deeper on NCT06476275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06476275.